Carcinoma in situ of the skin of the right lower limb, including the hip, is a localized form of skin cancer characterized by abnormal cell growth confined to the epidermis. This condition is primarily caused by prolonged sun exposure, genetic predisposition, or exposure to carcinogenic substances. Accurate coding with ICD-10 Code D04.71 is essential for precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate treatment and resource allocation.
ICD-10 Code D04.71 represents carcinoma in situ of the skin specifically located on the right lower limb, including the hip. This code is used when documenting cases of non-invasive skin cancer that has not yet spread beyond the epidermis. It is crucial for clinical documentation and billing, particularly when distinguishing between different types of skin lesions and ensuring appropriate treatment plans.
Carcinoma in situ of the skin of the right lower limb, including the hip, is a significant dermatological condition that requires prompt medical attention. It arises from the uncontrolled growth of abnormal skin cells, often linked to UV radiation exposure. Early detection and treatment are vital to prevent progression to invasive cancer.
ICD-10 Code D04.71 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to carcinoma in situ of the skin. This code is relevant in both acute and chronic care settings, facilitating accurate clinical workflows and ensuring comprehensive patient care.
In SOAP notes, ICD-10 Code D04.71 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Prompt treatment of carcinoma in situ of the skin is crucial to prevent progression to invasive cancer. Surgical excision is the primary treatment modality.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.71 is critical in medical billing, particularly in hospital and outpatient settings, ensuring accurate claims for skin cancer treatment.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign lesion, face, ears, scalp, neck; excised diameter up to 4.0 cm. |
| 11100 | Biopsy of skin, excisional, including closure. |
| 99213 | Established patient office visit, level 3. |
Common Questions About Using ICD-10 Code D04.71 for Carcinoma in situ of skin of right lower limb, including hip
What are the common symptoms of carcinoma in situ?
Common symptoms include a persistent red or scaly patch on the skin, which may be asymptomatic or cause mild itching. It is important to monitor any changes in the lesion.
How is carcinoma in situ diagnosed?
Diagnosis is typically made through a skin biopsy, where a sample of the lesion is examined histologically to confirm the presence of atypical cells.
What treatment options are available for carcinoma in situ?
Treatment usually involves surgical excision of the lesion. In some cases, topical chemotherapy may be considered, depending on the patient's condition.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a form of skin cancer, but it is non-invasive, meaning it has not spread beyond the epidermis.
Clinical Notes
SOAP notes
DAP notes
AI medical notes